Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 52,450
-1,250 (-2.33%)
Aug 29, 2025, 12:40 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 2.34 trillion as of August 28, 2025. Its market cap has decreased by -44.55% in one year.
Market Cap
2.34T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
90.25
Stock Price
52,450.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.34T, an increase of 3,419.11%. That is a compound annual growth rate of 19.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 2,335.68B | -5.30% |
| Dec 30, 2024 | 2,466.43B | -35.41% |
| Dec 28, 2023 | 3,818.49B | 44.48% |
| Dec 29, 2022 | 2,642.93B | -43.45% |
| Dec 30, 2021 | 4,673.68B | -46.31% |
| Dec 30, 2020 | 8,705.45B | 511.51% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.03T |
| Celltrion | 37.98T |
| ALTEOGEN | 22.34T |
| Yuhan | 8,627.98B |
| SK Biopharmaceuticals | 7,800.00B |
| Peptron | 7,396.91B |
| PharmaResearch | 7,106.52B |
| LigaChem Biosciences | 5,379.81B |